Le Chatelier, E., et al. “Richness of Human Gut Microbiome Correlates with Metabolic Markers”.
Lee, S. M., et al. “Bacterial Colonization Factors Control Specificity and Stability of the Gut Microbiota”.
Lee, Y. K., et al. “Proinflammatory T-Cell Responses to Gut Microbiota Promote Experimental Autoimmune Encephalomyelitis”.
Lewis, S. J., and K. W. Heaton. “Stool Form Scale as a Useful Guide to Intestinal Transit Time”.
Ley, R. E., et al. “Obesity Alters Gut Microbial Ecology”.
Lin, A., et al. “Distinct Distal Gut Microbiome Diversity and Composition in Healthy Children from Bangladesh and the United States”.
Lin, P. W., and B. J. Stoll. “Necrotising Enterocolitis”.
Lyte, M., et al. “Induction of Anxiety-Like Behavior in Mice During the Initial Stages of Infection with the Agent of Murine Colonic Hyperplasia Citrobacter Rodentium”.
Machiels, K., et al. “A Decrease of the Butyrate-Producing Species Roseburia Hominis and Faecalibacterium Prausnitzii Defines Dysbiosis in Patients with Ulcerative Colitis”.
Marcobal, A., “Bacteroides in the Infant Gut Consume Milk Oligosaccharides via Mucus-Utilization Pathways”.
Martens, E. C., et al. “The Devil Lies in the Details: How Variations in Polysaccharide Fine-Structure Impact the Physiology and Evolution of Gut Microbes”.
McDonald, L. C., et al. “Vital Signs: Preventing Clostridium difficile Infections”.
McGovern, P. E., et al. “Fermented Beverages of Pre- and Proto-Historic China”.
Merenstein, D., et al. “Use of a Fermented Dairy Probiotic Drink Containing Lactobacillus Casei (DN-114 001) to Decrease the Rate of Illness in Kids: The Drink Study. A Patient-Oriented, Double-Blind, Cluster-Randomized, Placebo-Controlled, Clinical Trial”.
Messaoudi, M., et al. “Assessment of Psychotropic-Like Properties of a Probiotic Formulation (Lactobacillus Helveticus R0052 and Bifidobacterium Longum R0175) in Rats and Human Subjects”.
Mueller, S., et al. “Differences in Fecal Microbiota in Different European Study Populations in Relation to Age, Gender, and Country: A Cross-Sectional Study”.
Neufeld, K. M., et al. “Reduced Anxiety-Like Behavior and Central Neurochemical Change in Germ-Free Mice”.
Ng, K. M., et al. “Microbiota-Liberated Host Sugars Facilitate Post-Antibiotic Expansion of Enteric Pathogens”.
Nieuwdorp, M., A. Vrieze, and W. M. de Vos. “Reply to Konstantinov and Peppelenbosch”.
Olszak, T., et al. “Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function”.
O’Mahony, L., et al. “Lactobacillus and Bifidobacterium in Irritable Bowel Syndrome: Symptom Responses and Relationship to Cytokine Profiles”.
O’Mahony, S. M., et al. “Early Life Stress Alters Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and Psychiatric Illnesses”.
O’Mahony, S. M., et al. “Maternal Separation as a Model of Brain-Gut Axis Dysfunction”.
Palmer, C., et al. “Development of the Human Infant Intestinal Microbiota”.
Petersson, J., et al. “Importance and Regulation of the Colonic Mucus Barrier in a Mouse Model of Colitis”.
Petrof, E. O., et al. “Stool Substitute Transplant Therapy for the Eradication of Clostridium Difficile Infection: ‘Repoopulating’ the Gut”.
Rabbani, G. H., et al. “Green Banana Reduces Clinical Severity of Childhood Shigellosis: A Double-Blind, Randomized, Controlled Clinical Trial”.